ATE449966T1 - Biochemische marker für akute lungenembolie - Google Patents
Biochemische marker für akute lungenembolieInfo
- Publication number
- ATE449966T1 ATE449966T1 AT06120782T AT06120782T ATE449966T1 AT E449966 T1 ATE449966 T1 AT E449966T1 AT 06120782 T AT06120782 T AT 06120782T AT 06120782 T AT06120782 T AT 06120782T AT E449966 T1 ATE449966 T1 AT E449966T1
- Authority
- AT
- Austria
- Prior art keywords
- amount
- pulmonary embolism
- acute
- biochemical markers
- lung embolism
- Prior art date
Links
- 230000001154 acute effect Effects 0.000 title abstract 4
- 208000010378 Pulmonary Embolism Diseases 0.000 title 1
- 208000005189 Embolism Diseases 0.000 abstract 4
- 210000004072 lung Anatomy 0.000 abstract 4
- 102400001263 NT-proBNP Human genes 0.000 abstract 1
- 230000001684 chronic effect Effects 0.000 abstract 1
- 108010008064 pro-brain natriuretic peptide (1-76) Proteins 0.000 abstract 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/575—Hormones
- G01N2333/58—Atrial natriuretic factor complex; Atriopeptin; Atrial natriuretic peptide [ANP]; Brain natriuretic peptide [BNP, proBNP]; Cardionatrin; Cardiodilatin
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/12—Pulmonary diseases
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Food Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Endocrinology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Diabetes (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Surgical Instruments (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP06120782A EP1901072B1 (de) | 2006-09-15 | 2006-09-15 | Biochemische Marker für akute Lungenembolie |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE449966T1 true ATE449966T1 (de) | 2009-12-15 |
Family
ID=37908012
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT06120782T ATE449966T1 (de) | 2006-09-15 | 2006-09-15 | Biochemische marker für akute lungenembolie |
Country Status (8)
| Country | Link |
|---|---|
| US (3) | US7651679B2 (de) |
| EP (1) | EP1901072B1 (de) |
| JP (1) | JP4689651B2 (de) |
| CN (1) | CN101144811A (de) |
| AT (1) | ATE449966T1 (de) |
| CA (1) | CA2601147A1 (de) |
| DE (1) | DE602006010705D1 (de) |
| ES (1) | ES2334155T3 (de) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1731910A1 (de) * | 2005-06-07 | 2006-12-13 | F. Hoffmann-La Roche Ag | Gebrauch von NT-proANP und NT-proBNP für die Diagnose von Herzkrankheiten |
| ES2549460T3 (es) * | 2009-11-03 | 2015-10-28 | F. Hoffmann-La Roche Ag | NT-pro ANP y sFlt-1 para la diferenciación entre los eventos isquémicos y circulatorios |
| EP3290924B1 (de) * | 2011-12-01 | 2021-10-13 | Roche Diagnostics GmbH | Nt-pro-anp und nt-pro-bnp zur diagnose eines schlaganfalls |
| JP6328655B2 (ja) | 2012-11-15 | 2018-05-23 | オーソ・クリニカル・ダイアグノスティックス・インコーポレーテッド | 反応時間を使用してアッセイを較正すること |
| CN109652525A (zh) * | 2018-11-30 | 2019-04-19 | 深圳市人民医院 | 肺血栓栓塞症基因面板试剂盒及其应用 |
| US11931207B2 (en) | 2018-12-11 | 2024-03-19 | Eko.Ai Pte. Ltd. | Artificial intelligence (AI) recognition of echocardiogram images to enhance a mobile ultrasound device |
| US11446009B2 (en) | 2018-12-11 | 2022-09-20 | Eko.Ai Pte. Ltd. | Clinical workflow to diagnose heart disease based on cardiac biomarker measurements and AI recognition of 2D and doppler modality echocardiogram images |
| US12400762B2 (en) | 2018-12-11 | 2025-08-26 | Eko.Ai Pte. Ltd. | Automatic clinical workflow that recognizes and analyzes 2D and doppler modality echocardiogram images for automated cardiac measurements and diagnosis of cardiac amyloidosis and hypertrophic cardiomyopathy |
| US12001939B2 (en) | 2018-12-11 | 2024-06-04 | Eko.Ai Pte. Ltd. | Artificial intelligence (AI)-based guidance for an ultrasound device to improve capture of echo image views |
| US12322100B2 (en) | 2018-12-11 | 2025-06-03 | Eko.Ai Pte. Ltd. | Automatic clinical workflow that recognizes and analyzes 2D and doppler modality echocardiogram images for automated cardiac measurements and grading of aortic stenosis severity |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5744101A (en) * | 1989-06-07 | 1998-04-28 | Affymax Technologies N.V. | Photolabile nucleoside protecting groups |
| GB9211686D0 (en) | 1992-06-03 | 1992-07-15 | Medisinsk Innovation A S | Chemical compounds |
| US7632647B2 (en) | 2001-04-13 | 2009-12-15 | Biosite Incorporated | Use of B-type natriuretic peptide as a prognostic indicator in acute coronary syndromes |
| EP1322957B1 (de) | 2001-05-04 | 2009-08-12 | Biosite Incorporated | Diagnostische marker für akute herzerkrankungen und verfahren des gebrauchs |
| JP2006526140A (ja) * | 2002-12-24 | 2006-11-16 | バイオサイト インコーポレイテッド | 鑑別診断のためのマーカーおよびその使用方法 |
| GB2403533A (en) * | 2003-06-30 | 2005-01-05 | Orion Corp | Atrial natriuretic peptide and brain natriuretic peptide and assays and uses thereof |
| JP4828550B2 (ja) * | 2005-02-17 | 2011-11-30 | エフ．ホフマン−ラ ロシュ アーゲー | 心機能障害を診断するためのＮＴ−ｐｒｏＡＮＰ／ＮＴ−ｐｒｏＢＮＰ比の使用 |
| DE102005016369A1 (de) | 2005-04-09 | 2006-10-12 | Degussa Ag | Verfahren zur kontinuierlichen Herstellung von Methylmercaptan |
-
2006
- 2006-09-15 AT AT06120782T patent/ATE449966T1/de active
- 2006-09-15 EP EP06120782A patent/EP1901072B1/de active Active
- 2006-09-15 DE DE602006010705T patent/DE602006010705D1/de active Active
- 2006-09-15 ES ES06120782T patent/ES2334155T3/es active Active
-
2007
- 2007-09-04 US US11/849,407 patent/US7651679B2/en active Active
- 2007-09-11 CA CA002601147A patent/CA2601147A1/en not_active Abandoned
- 2007-09-14 JP JP2007239009A patent/JP4689651B2/ja active Active
- 2007-09-14 CN CNA2007101536849A patent/CN101144811A/zh active Pending
-
2009
- 2009-12-07 US US12/631,926 patent/US8501155B2/en active Active
- 2009-12-07 US US12/632,026 patent/US8497095B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| US20100081164A1 (en) | 2010-04-01 |
| JP4689651B2 (ja) | 2011-05-25 |
| JP2008102129A (ja) | 2008-05-01 |
| US8497095B2 (en) | 2013-07-30 |
| US20090081719A1 (en) | 2009-03-26 |
| EP1901072B1 (de) | 2009-11-25 |
| EP1901072A1 (de) | 2008-03-19 |
| US20100203571A1 (en) | 2010-08-12 |
| US7651679B2 (en) | 2010-01-26 |
| CN101144811A (zh) | 2008-03-19 |
| ES2334155T3 (es) | 2010-03-05 |
| DE602006010705D1 (de) | 2010-01-07 |
| US8501155B2 (en) | 2013-08-06 |
| CA2601147A1 (en) | 2008-03-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2005098446A3 (en) | Biomarkers for ovarian cancer | |
| WO2008015254A3 (en) | Means and methods for assessing the risk of cardiac interventions based on gdf-15 | |
| WO2006126008A3 (en) | Improved immunoassay methods | |
| DK1540010T3 (da) | Anvendelse af biomarkører til påvisning af ovariecancer | |
| WO2004099432A3 (en) | Identification of biomarkers for detecting pancreatic cancer | |
| ATE485514T1 (de) | Immunoassay mit mehreren analyten | |
| IL287810A (en) | Kits for detecting one or more target nucleic acid analytes in a sample and methods of making and using the same | |
| WO2010081981A3 (fr) | Procédé de détermination de la teneur d'une pluralité de composés contenus dans un fluide de forage. | |
| WO2008106648A3 (en) | Immunoassays exhibiting a reduction in prozone phenomena | |
| DK2341344T3 (da) | Fremgangsmåde til diagnosticering af en polycystisk nyresygdom | |
| ATE449966T1 (de) | Biochemische marker für akute lungenembolie | |
| WO2010002911A3 (en) | Methods and materials for monitoring myeloma using quantitative mass spetrometry | |
| NZ576061A (en) | Biomarkers | |
| ATE415662T1 (de) | Bestimmung der tatsächlichen zeit, die ein prozessor bei der ausführung eines codeteiles aufwendet | |
| WO2006078289A3 (en) | Bio-barcode based detection of target analytes | |
| WO2008011158A3 (en) | Method of detecting and/ or measuring hepcidin in a sample | |
| ES2364314T8 (es) | Detección y predicción de preeclampsia. | |
| EP2062052A4 (de) | Verfahren zur bestimmung einer analytkonzentration | |
| WO2008129296A3 (en) | Disease markers | |
| WO2009129173A3 (en) | Methods, antibodies and kits for detecting cerebrospinal fluid in a sample | |
| DK3742153T3 (da) | Fremgangsmåde til kvantificering af det samlede indhold af saponiner i en prøve, navnlig i en kompleks prøve | |
| DK2118666T3 (da) | Fremgangsmåde til normalisering af koncentrationen af analytter i en urinprøve | |
| WO2008131261A3 (en) | Peptide biomarkers of cardiovascular disease | |
| WO2009141352A3 (en) | Risk analysis in patients with and without metabolic syndrome | |
| WO2006102526A3 (en) | Identification of biomarkers by serum protein profiling |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1901072 Country of ref document: EP |